Measles and Rubella Elimination Project

-Decreasing the prevalence of children dropping out from vaccination and improve the MCV1 and MCV2 coverage.

• Implementing nationwide supplemental immunization activities (SIAs) targeting children aged 9 to 59 months.
• Reducing the high dropout rate between MCV1 to MCV2 and improve the overall population immunity and support achievement of full childhood immunization.
• Improving the measles immunization coverage to increase population immunity and interrupt the occurrence of repeated outbreaks.
• Supporting ongoing research and development of the measles-rubella microneedle patch by Georgia Institute of Technology in collaboration with the United States Centers for Disease Control and Prevention (CDC).
• Supporting UNICEF to assist non GAVI-eligible Middle-Income Countries (MICs), where it is challenging to mobilize external resources to augment governments' effort in the measles control and elimination. The aim is to achieve and maintain high levels of population immunity by providing high vaccination coverage with two doses of measles containing vaccines and thereby contributing to the goal of reducing measles annual deaths by 95 per cent (as compared to 2000 estimates) in the selected MICs.
• Enabling UNICEF to deploy external communication staff to help the Measles & Rubella Initiative (M&RI) in advocacy and external communication efforts.